论文部分内容阅读
目的:分析孕期联合用药在预防艾滋病母婴阻断中干预效果。方法:对碧江区2006年1月-2013年12月期间确诊50例艾滋病感染孕产妇及分娩婴儿用药情况与婴儿最终感染状况,分为对照组和观察组,每组各25例。对照组采用齐多夫定单方案治疗,观察组采用齐多夫定+拉米夫定+克力芝或依非韦伦联合服药方案治疗,分析不同药物的阻断疗效。结果:观察组婴儿18月龄抗体检测均为阴性,没有感染艾滋病病毒,对照组中有23例婴儿18月龄抗体检测为阴性,2例最后确诊为阳性,艾滋病母婴传播的阻断效果,观察组为100.00%,高于对照组的92.00%,其差异具有统计学意义,P<0.05。结论:在药物阻断艾滋病母婴传播的效果方面,母亲联合用药的效果更好,临床适宜推广应用。
Objective: To analyze the effect of combination therapy during pregnancy in preventing mother-infant blockage of AIDS. Methods: The clinical data of 50 cases of AIDS-infected pregnant women and childbirths and the final infection status of infants in Bijiang district from January 2006 to December 2013 were divided into control group and observation group, 25 cases in each group. The control group was treated with Zidovan’s single regimen. The observation group was treated with the combination of zidovudine + lamivudine + gliclazide or efavirenz. The blocking effect of different drugs was analyzed. Results: 18-month-old infants in the observation group were negative for antibodies and HIV-1 was not detected in the infants. Twenty-three of the 18 infants in the control group were negative for 18-month-old antibodies, 2 were finally diagnosed as positive and HIV- The observation group was 100.00%, higher than the control group 92.00%, the difference was statistically significant, P <0.05. Conclusion: In the aspect of drug blocking the effect of mother-to-child transmission of HIV, the combination effect of mother is better and the disease is suitable for clinical application.